PC
Zug, Switzerland · Europe
OncologyRare disease
FDAEMAPMDAMHRA
SCALE 270 studies
Open to sponsorsAdvanced-therapy activeView London, United Kingdom · Europe
OncologyRare disease
FDAEMAPMDAMHRA
SCALE 230 studies
Open to sponsorsSelectiveView Not stated as a therapeutic-area list. The company names immuno-oncology and T-cell biology as biologics/discovery focus areas; its offering is otherwise described by modality (small moleculespeptidesoligonucleotidesmAbs
FDA
SCALE 00 studies
Open to sponsorsSelectiveView Irvine, United States · North America
Not presented as a therapeutic-area list. Company service pages name oncology (PDXCDXorthotopicsyngeneic
SCALE 00 studies
Open to sponsorsGeneral clinicalView Company site lists OncologyDermatologyRespiratoryBiosimilars and Vaccines as therapeutic areas
SCALE 120 studies
Open to sponsorsGeneral clinicalView